Dental Malocclusion and Craniofacial Development in OI

NCT02934451 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2026-01-27

No results posted yet for this study

Summary

Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss and pain and difficulty getting around. People with moderate to severe OI may also be diagnosed with dentinogenesis imperfecta (DI). DI is characterized by grey or brown teeth that may chip and wear down and break easily. People with DI may also have skull and neck defects. These patients may have severe teeth misalignment resulting in clinically significant chewing problems. Teeth misalignment in OI is very hard to treat because of the quality and quantity of bone. The overall goal of this study is to improve dental health to improve the quality of life of people with OI.

Conditions

Sponsors & Collaborators

  • Shriners Hospitals for Children

    collaborator OTHER
  • Hospital for Special Surgery, New York

    collaborator OTHER
  • University of Nebraska

    collaborator OTHER
  • Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    collaborator OTHER
  • Children's National Research Institute

    collaborator OTHER
  • University of California, Los Angeles

    collaborator OTHER
  • Oregon Health and Science University

    collaborator OTHER
  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Jean-Marc Retrouvey, D.M.D. · McGill University

  • Reid Sutton, M.D. · Baylor College of Medicine

  • Frank Rauch, M.D. · Shriners Hospital for Children

Eligibility

Min Age
10 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934451 on ClinicalTrials.gov